Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
PHASE2
The primary objective of this study is to assess the efficacy of Glycopyrro...
Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients
N/A
This is a descriptive observational open non-comparative study of the safet...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 1
Start Date
2004-03
Trial ID
NCT00620516
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
PHASE2
The purpose of this study is to evaluate, after 1 week of dosing, the effic...
Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)
PHASE3
This is a multi-center, randomized, double-blind, parallel group, chronic d...